We are live on ! Find out more
OCRX

Ocera Therapeutics
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

33 hedge funds and large institutions have $33.3M invested in Ocera Therapeutics in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital inflows, than outflows

Capital inflows: $4.02M | Capital outflows: $3.75M

8% less funds holding

Funds holding: 36 → 33 (-3)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
33
Holders Change
-3
Holders Change %
-8.33%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
8
Reduced
9
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

OCRX Hedge Fund Activity: Q2 2014 in Review

33 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics (OCRX) for Q2 2014, worth a combined $33.3M — down 26% from $45.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of OCRX and 8 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 8 added.

The largest buyer was Pacific Alternative Asset Management Company (PAAMCO), adding an estimated $832K. The largest seller was Ghost Tree Capital, cutting an estimated $1.08M.

  • 33 institutional investors held Ocera Therapeutics (OCRX) as of Q2 2014, down from 36 in Q1 2014.
  • Funds reported $33.3M of Ocera Therapeutics stock for Q2 2014, down 26% quarter-over-quarter.
  • 8 funds opened new Ocera Therapeutics positions in Q2 2014 and 11 closed out, a net change of -3 holders.
  • The largest Ocera Therapeutics buyer in Q2 2014 was Pacific Alternative Asset Management Company (PAAMCO), an estimated $832K added.
  • The largest Ocera Therapeutics seller in Q2 2014 was Ghost Tree Capital, an estimated $1.08M sold.

Based on aggregated 13F filings for Q2 2014.